• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups.

作者信息

Giannini Margherita, Debrut Léa, Nespola Benoit, Velten Michel, Geny Bernard, Sibilia Jean, Meyer Alain

机构信息

Physiologie et Explorations Fonctionnelles Musculaires, University Hospital of Strasbourg, Strasbourg, France.

Centre de Recherche en Biomédecine, University of Strasbourg, UR3072, Strasbourg, France.

出版信息

Nat Rev Rheumatol. 2024 May;20(5):311-312. doi: 10.1038/s41584-024-01105-9.

DOI:10.1038/s41584-024-01105-9
PMID:38514811
Abstract
摘要

相似文献

1
Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups.当前的分类标准通过忽略亚组而低估了特发性炎性肌病的发病率。
Nat Rev Rheumatol. 2024 May;20(5):311-312. doi: 10.1038/s41584-024-01105-9.
2
Reply to: Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups.回复：当前的分类标准因忽略亚组而低估了特发性炎性肌病的发病率。
Nat Rev Rheumatol. 2024 May;20(5):313-314. doi: 10.1038/s41584-024-01106-8.
3
The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort.欧洲抗风湿病联盟/美国风湿病学会特发性炎性肌病分类标准在专家定义的 10 年发病队列中的表现。
Rheumatology (Oxford). 2019 Mar 1;58(3):468-475. doi: 10.1093/rheumatology/key343.
4
Diagnosis and classification of idiopathic inflammatory myopathies.特发性炎性肌病的诊断与分类
J Intern Med. 2016 Jul;280(1):39-51. doi: 10.1111/joim.12524.
5
[Acquired inflammatory myopathies: interest of specific autoantibodies for their classification].[获得性炎性肌病：特异性自身抗体对其分类的意义]
Rev Prat. 2015 May;65(5):607-12.
6
Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific Autoantibodies.2017 年欧洲风湿病学会联盟/美国风湿病学会特发性炎性肌病分类标准在肌炎特异性自身抗体患者中的性能。
Arthritis Rheumatol. 2022 Mar;74(3):508-517. doi: 10.1002/art.41964. Epub 2022 Feb 1.
7
External validation of the EULAR/ACR idiopathic inflammatory myopathies classification criteria with a Japanese paediatric cohort.对一个日本儿科队列进行 EULAR/ACR 特发性炎性肌病分类标准的外部验证。
Rheumatology (Oxford). 2021 Feb 1;60(2):802-808. doi: 10.1093/rheumatology/keaa274.
8
Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.基于临床表现和肌炎特异性自身抗体的特发性炎性肌病新分类系统的建立。
JAMA Neurol. 2018 Dec 1;75(12):1528-1537. doi: 10.1001/jamaneurol.2018.2598.
9
Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort.新的 EULAR/ACR 特发性炎性肌病（IIM）分类标准在大型单中心 IIM 队列中的表现。
Semin Arthritis Rheum. 2020 Jun;50(3):492-497. doi: 10.1016/j.semarthrit.2019.12.001. Epub 2019 Dec 28.
10
Classification criteria for the idiopathic inflammatory myopathies.特发性炎性肌病的分类标准。
Curr Opin Rheumatol. 1997 Nov;9(6):527-35. doi: 10.1097/00002281-199711000-00008.

引用本文的文献

1
Reply to: Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups.回复：当前的分类标准因忽略亚组而低估了特发性炎性肌病的发病率。
Nat Rev Rheumatol. 2024 May;20(5):313-314. doi: 10.1038/s41584-024-01106-8.

本文引用的文献

1
Epidemiology of the idiopathic inflammatory myopathies.特发性炎症性肌病的流行病学
Nat Rev Rheumatol. 2023 Nov;19(11):695-712. doi: 10.1038/s41584-023-01033-0. Epub 2023 Oct 6.
2
Refining Incidence and Characteristics of Inflammatory Myopathies: A Quadruple-Source Capture-Recapture Survey Using the 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria.细化炎症性肌病的发病情况和特征：采用 2017 年欧洲抗风湿病联盟/美国风湿病学会分类标准的四重源捕获-再捕获调查。
Arthritis Rheumatol. 2023 Oct;75(10):1850-1855. doi: 10.1002/art.42561. Epub 2023 Aug 4.
3
Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis.
硬皮病性肌炎：系统性硬化症和自身免疫性肌炎谱中的一种独特新型实体。对护理和发病机制的影响。
Front Immunol. 2023 Jan 26;13:974078. doi: 10.3389/fimmu.2022.974078. eCollection 2022.
4
Defining anti-synthetase syndrome: a systematic literature review.抗合成酶综合征的定义：系统文献回顾。
Clin Exp Rheumatol. 2022 Feb;40(2):309-319. doi: 10.55563/clinexprheumatol/8xj0b9. Epub 2022 Feb 25.
5
Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific Autoantibodies.2017 年欧洲风湿病学会联盟/美国风湿病学会特发性炎性肌病分类标准在肌炎特异性自身抗体患者中的性能。
Arthritis Rheumatol. 2022 Mar;74(3):508-517. doi: 10.1002/art.41964. Epub 2022 Feb 1.
6
Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes.抗-Ku 综合征伴 CK 升高和抗-Ku 综合征伴抗 dsDNA 是两种不同的实体，具有不同的结局。
Ann Rheum Dis. 2019 Aug;78(8):1101-1106. doi: 10.1136/annrheumdis-2018-214439. Epub 2019 May 24.
7
Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies.抗 PM/Scl 自身抗体患者的肌肉和肌肉外临床特征。
Neurology. 2018 Jun 5;90(23):e2068-e2076. doi: 10.1212/WNL.0000000000005638. Epub 2018 May 4.
8
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.抗 Jo-1 阳性抗合成酶综合征的临床谱随时间变化：一项国际回顾性多中心研究的结果
Medicine (Baltimore). 2015 Aug;94(32):e1144. doi: 10.1097/MD.0000000000001144.
9
Incidence and prevalence of inflammatory myopathies: a systematic review.炎性肌病的发病率和患病率：系统评价。
Rheumatology (Oxford). 2015 Jan;54(1):50-63. doi: 10.1093/rheumatology/keu289. Epub 2014 Jul 26.